• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Klotz discusses accuracy of miR Sentinel PCC4 Test for prostate cancer


“We think given the accuracy that this is potentially a game changer,” says Laurence Klotz, MD, FRCSC.

In this video, Laurence Klotz, MD, FRCSC, discusses the miR Sentinel PCC4 Test and how it is advantageous compared to other currently available prostate cancer tests. Klotz is a professor of surgery at the University of Toronto, and the chair of prostate cancer research at the Sunnybrook Health Sciences Centre, Ontario, Canada.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.